Viridian Therapeutics, Inc. (FRA:1S1)
Germany · Delayed Price · Currency is EUR 27.68
+0.67 (2.48%)
Last updated: Dec 1, 2025, 8:06 AM CET
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of €2.58 billion as of December 1, 2025. Its market cap has increased by 54.19% in one year.
Market Cap
2.58B
Enterprise Value
2.34B
Revenue
60.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€27.68
Market Cap Chart
Since February 14, 2017, Viridian Therapeutics's market cap has increased from 162.74M to 2.58B, an increase of 1,486.56%. That is a compound annual growth rate of 36.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 2.63B | 79.35% |
| Dec 31, 2024 | 1.47B | 41.55% |
| Dec 29, 2023 | 1.04B | -5.81% |
| Dec 30, 2022 | 1.10B | 191.32% |
| Dec 31, 2021 | 377.62M | 618.50% |
| Dec 31, 2020 | 52.56M | 286.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |